OncoSec Medical Closes $13.6 Million Registered Direct Offering

Go back to OncoSec Medical Closes $13.6 Million Registered Direct Offering

Oncosec Medical (ONCS) Reports Wider Nine-Month Loss of $1.19/Share for 2015; Closes Direct Offering

June 9, 2015 6:46 AM UTC

Oncosec Medical Incorporated (Nasdaq: ONCS) announced financial results for the nine months ended April 30, 2015.

FINANCIAL RESULTS

For the nine months ended April 30, 2015, OncoSec reported a net loss of $14.7 million, or $1.19 per share, compared to a net loss of $8.5 million, or $0.96 per share, for the same period last year. There were no revenues for the nine months ended April 30, 2015 or April 30, 2014.

Research and development expenses were $9.3 million for the nine months ended April 30, 2015, compared to $3.9 million for the nine months ended April 30, 2014. This increase in research and development expenses was primarily a... More